Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.78% | -12.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.78% | -12.17% | |||
| Cost of Revenue | -1.81% | -9.22% | |||
| Gross Profit | 157.15% | -27.20% | |||
| SG&A Expenses | -14.16% | -8.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.60% | -9.47% | |||
| Operating Income | 41.55% | 5.90% | |||
| Income Before Tax | -39.56% | 39.09% | |||
| Income Tax Expenses | 106.52% | 97.85% | |||
| Earnings from Continuing Operations | -39.86% | 35.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 40.17% | -35.53% | |||
| Net Income | -39.62% | 35.45% | |||
| EBIT | 41.55% | 5.90% | |||
| EBITDA | 64.79% | 9.46% | |||
| EPS Basic | -39.30% | 35.66% | |||
| Normalized Basic EPS | 404.98% | -233.81% | |||
| EPS Diluted | -39.30% | 35.66% | |||
| Normalized Diluted EPS | 404.98% | -233.81% | |||
| Average Basic Shares Outstanding | 0.27% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||